Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPRES: Imatinib in severe pulmonary arterial hypertension
NCT00902174Phase 3Completed
- Sponsor
- Novartis
- Start
- Sep 2009
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of imatinib in pulmonary arterial hypertension (PAH), sponsored by Novartis. Started Sep 2009; status: completed.
02
Drugs
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00902174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00902174.